Arginine-substituted Mastoparan-C derivatives combat dual bacterial pathogens: in vitro mechanistic insights and in vivo efficacy in polymicrobial wounds
Microbiology Spectrum · 04.08.2026 · 14 (8)
DOI: 10.1128/spectrum.04219-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 04.08.2026. Verfasst von Luyao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Medicine, Shenyang Agricultural University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Arginine, Wound Infection, Anti-Bacterial Agents, Peptides. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liaoning Provincial Science and Technology Program Joint Project, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The synergistic interactions in multi-pathogen infections compromise wound healing and limit therapeutic efficacy. In this study, we designed and synthesized arginine-substituted derivatives of the antimicrobial peptide Mastoparan-C (MP-C). Among them, Arg²MP-C and Arg 4.11.12 MP-C exhibited potent, broad-spectrum activity against both Escherichia coli and Staphylococcus aureus . Their enhanced antibacterial activity is associated with increased positive charge and optimized hydrophobicity. Mechanistically, both peptides employ a dual-target strategy, disrupting bacterial membranes and binding genomic DNA; Arg²MP-C acted most rapidly against the E. coli envelope, while Arg 4.11.12 MP-C caused the strongest membrane damage to S. aureus . In a murine polymicrobial wound model, Arg²MP-C treatment nearly achieved complete wound closure by day 10, significantly reduced bacterial loads, and promoted tissue regeneration. This study demonstrates that arginine engineering can yield peptides with potent, multi-mechanistic action, identifying Arg²MP-C as a promising candidate for combating polymicrobial wound infections. IMPORTANCE Wounds infected with multiple bacterial species are notoriously difficult to treat, often leading to poor healing and limited effectiveness of existing therapies. In this study, we developed new antimicrobial peptides by introducing arginine substitutions into a natural peptide called Mastoparan-C. Two of our engineered peptides, Arg²MP-C and Arg 4.11.12 MP-C, showed potent activity against two common wound pathogens, Escherichia coli and Staphylococcus aureus . These peptides work through a dual mechanism: disrupting bacterial membranes and binding to bacterial DNA. In a mouse model of mixed-infection wounds, treatment with Arg²MP-C led to nearly complete wound closure by day 10, drastically reduced bacterial counts, and promoted tissue repair. Our findings highlight arginine engineering as a promising strategy to create next‑generation antimicrobial agents that can effectively combat complex polymicrobial wound infections, addressing a critical unmet need in clinical wound care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Medicine, Shenyang Agricultural University, Shenyang, Liaoning, China.
ORCID-Profile: Fei Mo
Förderung
- Liaoning Provincial Science and Technology Program Joint Project
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, L., Huang, A., Lu, M., Wang, J., Wang, Y., Mo, F., & Liu, M. (2026). Arginine-substituted Mastoparan-C derivatives combat dual bacterial pathogens: in vitro mechanistic insights and in vivo efficacy in polymicrobial wounds. Microbiology Spectrum, 14(8). https://doi.org/10.1128/spectrum.04219-25
Vancouver
Zhang L, Huang A, Lu M, Wang J, Wang Y, Mo F, et al. Arginine-substituted Mastoparan-C derivatives combat dual bacterial pathogens: in vitro mechanistic insights and in vivo efficacy in polymicrobial wounds. Microbiology Spectrum. 2026;14(8). doi:10.1128/spectrum.04219-25
BibTeX
@article{Zhang2026,
author = {Zhang, Luyao and Huang, Anqi and Lu, Mingyu and Wang, Jingjing and Wang, Yingyu and Mo, Fei and Liu, Mingchun},
title = {Arginine-substituted Mastoparan-C derivatives combat dual bacterial pathogens: in vitro mechanistic insights and in vivo efficacy in polymicrobial wounds},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {8},
doi = {10.1128/spectrum.04219-25}
}
EUVIMED